Editorial
doi: 10.1200/JCO.2011.39.4270.
Epub 2011 Dec 5.
Role of nonclinical factors in the receipt of high-quality systemic adjuvant breast cancer treatment
- PMID: 22147739
- DOI: 10.1200/JCO.2011.39.4270
Item in Clipboard
Editorial
Role of nonclinical factors in the receipt of high-quality systemic adjuvant breast cancer treatment
J Clin Oncol.
.
No abstract available
Comment on
-
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5. J Clin Oncol. 2012. PMID: 22147735
Similar articles
-
Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5. J Clin Oncol. 2012. PMID: 22147735
-
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level.Breast Cancer Res Treat. 2016 Sep;159(2):357-65. doi: 10.1007/s10549-016-3940-7. Epub 2016 Aug 12. Breast Cancer Res Treat. 2016. PMID: 27514397
-
Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.J Clin Oncol. 2007 Jun 20;25(18):2522-7. doi: 10.1200/JCO.2006.10.2749. J Clin Oncol. 2007. PMID: 17577029
-
Comparing guidelines for adjuvant endocrine therapy in postmenopausal women with breast cancer: a coming of age.Expert Rev Anticancer Ther. 2011 Feb;11(2):277-86. doi: 10.1586/era.10.218. Expert Rev Anticancer Ther. 2011. PMID: 21342045 Review.
-
Guidelines for the adjuvant treatment of postmenopausal women with endocrine-responsive breast cancer: past, present and future recommendations.Eur J Cancer. 2007 Jan;43(1):46-52. doi: 10.1016/j.ejca.2006.09.003. Epub 2006 Nov 7. Eur J Cancer. 2007. PMID: 17085045 Review.
Cited by
-
Changes in initiation of adjuvant endocrine therapy for breast cancer after state health reform.BMC Cancer. 2021 May 1;21(1):487. doi: 10.1186/s12885-021-08149-0. BMC Cancer. 2021. PMID: 33933027 Free PMC article.
-
Are there socio-economic inequalities in utilization of predictive biomarker tests and biological and precision therapies for cancer? A systematic review and meta-analysis.BMC Med. 2020 Oct 23;18(1):282. doi: 10.1186/s12916-020-01753-0. BMC Med. 2020. PMID: 33092592 Free PMC article.
-
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update.J Clin Oncol. 2014 Jul 20;32(21):2255-69. doi: 10.1200/JCO.2013.54.2258. Epub 2014 May 27. J Clin Oncol. 2014. PMID: 24868023 Free PMC article.
-
The Influence of Socioeconomic Status on Racial/Ethnic Disparities among the ER/PR/HER2 Breast Cancer Subtypes.J Cancer Epidemiol. 2015;2015:813456. doi: 10.1155/2015/813456. Epub 2015 Aug 3. J Cancer Epidemiol. 2015. PMID: 26339244 Free PMC article.
-
Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010.BMC Cancer. 2013 Oct 2;13:449. doi: 10.1186/1471-2407-13-449. BMC Cancer. 2013. PMID: 24083624 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
